Mainz Biomed and Instituto de Microecologia Announce Collaboration

Mainz Biomed and Instituto de Microecologia Partnership Mainz Biomed, a molecular genetics company specializing in early cancer diagnosis, has announced that it is adding Instituto de Microecologia in Madrid to its growing network of laboratory partners across Europe and in specific international markets. Mainz Biomed's flagship product ColoAlert®, is a highly effective and easy-to-use home detection test used in colorectal cancer screening. Instituto de Microecologia has been a pioneer in microbiota and food sensitivity research for over 60 years, focusing on raising awareness about the importance of intestinal health through microbiological analysis and diagnosis of microbiota profiles and specific health parameters. The start of active commercialization in the Spanish and Portuguese markets signals Mainz Biomed's ongoing expansion in Europe. Mainz Biomed Chief Executive Officer Guido Baechler stated, "As we continue to establish partnerships with third-party diagnostic laboratories such as Instituto de Microecologia for the test kit process, our goal is to increase consumer access to affordable and reliable CRC screening tests like ColoAlert. Early screening has the potential to save lives by significantly impacting the treatment and prevention of this fatal disease." Instituto de Microecologia, recognized for its pioneering work in intestinal health across Spain, provides various diagnostic and analytical services and continuously develops its scientific and technical capabilities through internal research as well as external collaborations. The institute uses the most innovative diagnostic techniques, continuously reviewing procedures to ensure the highest quality standards and reliability in diagnostic results. Source